[1]Yeung MSY, Zdunek S, Bergmann O, et al. Dynamics of oligodendrocyte generation and myelination in the human brain[J]. Cell, 2014, 159(4): 766-774.
[2]Tripathi RB, Jackiewicz M, McKenzie IA, et al. Remarkable Stability of myelinating oligodendrocytes in mice[J]. Cell Rep, 2017, 21(2): 316-323.
[3]Fard MK, van der Meer F, Snchez P, et al. BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions[J]. Sci Transl Med, 2017, 9(419):7816.
[4]Xiao L, Ohayon D, McKenzie IA, et al. Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning[J]. Nat Neurosci, 2016, 19(9): 1210-1217.
[5]Zhang X, Huang N, Xiao L, et al. Replenishing the aged brains: targeting oligodendrocytes and myelination [J] Front Aging Neurosci, 2021, 13:760200.
[6]Skaper SD. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases[J]. Prog Brain Res, 2019, 245: 119-144.
[7]Minocha S, Valloton D, Brunet I, et al. NG2 glia are required for vessel network formation during embryonic development[J]. Elife, 2015, 4:e09102.
[8]Yuen TJ, Silbereis JC, Griveau A, et al. Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis[J]. Cell, 2014, 158(2): 383-396.
[9]Seo JH, Maki T, Maeda M, et al. Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-β signaling[J]. PLoS One, 2014, 9(7): e103174.
[10]Falcão AM, van Bruggen D, Marques S, et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis[J]. Nat Med, 2018,24(12): 1837-1844.
[11]Kokkosis AAO, Madeira MAO, Mullahy MR, et al. Chronic stress disrupts the homeostasis and progeny progression of oligodendroglial lineage cells, associating immune oligodendrocytes with prefrontal cortex hypomyelination[J]. Mol Psychiatry,2022,27(6):2833-2848.
[12]Moyon S, Dubessy AL, Aigrot MS, et al. Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration[J]. J Neurosci, 2015, 35(1): 4-20.
[13]Li H, Chen Y, Niu J, et al. New insights into the immunologic role of oligodendrocyte lineage cells in demyelination diseases[J]. J Biomed Res, 2022, 36(5):343-352.
[14]Nishiyama A, Chang A, Trapp BD. NG2+ glial cells: a novel glial cell population in the adult brain [J]. J Neuropathol Exp Neurol, 1999, 58(11): 1113-1124.
[15]Kirby L, Jin J, Cardona JG, et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination[J]. Nat Commun, 2019, 10(1): 3887.
[16]Zeis T, Enz L, Schaeren-Wiemers N. The immunomodulatory oligodendrocyte[J]. Brain Res, 2016, 1641(Pt A): 139-148.
[17]Kang Z, Wang C, Zepp J, et al. Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells[J]. Nat Neurosci, 2013, 16(10): 1401-1408.
[18]Marro BS, Grist JJ, Lane TE. Inducible expression of CXCL1 within the central nervous system amplifies viral-induced demyelination[J]. J Immunol, 2016,196(4):1855-1864.
[19]Moore S, Meschkat M, Ruhwedel T, et al. A role of oligodendrocytes in information processing[J]. Nat Commun, 2020,11(1):5497.
[20]Watson AES, Goodkey K, Footz T, et al. Regulation of CNS precursor function by neuronal chemokines[J]. Neurosci Lett, 2020,715:134533.
[21]Niu J, Tsai HH, Hoi KK, et al. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation[J]. Nat Neurosci, 2019, 22(5): 709-718.
[22]Pan R, Zhang Q, Anthony SM, et al. Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS[J]. Proc Natl Acad Sci USA, 2020, 117(27): 15902-15910.
[23]Ramesh G, Benge S, Pahar B, et al. A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi [J]. J Neuroinflammation, 2012, 9: 72.
[24]Fern ndez-Casta?eda A, Chappell MS, Rosen DA, et al. The active contribution of OPCs to neuroinflammation is mediated by LRP1[J]. Acta Neuropathol, 2020,139(2):365-382.
[25]Galea I, Bechmann I, Perry VH. What is immune privilege (not) [J] Trends Immunol, 2007, 28(1): 12-18.
[26]Stephenson J, Nutma E, van der Valk P, et al. Inflammation in CNS neurodegenerative diseases[J]. Immunology, 2018, 154(2): 204-219.
[27]Petersen MA, Ryu JK, Chang KJ, et al, Fibrinogen activates BMP signaling in oligodendrocyte progenitor cells and inhibits remyelination after vascular damage[J]. Neuron, 2017, 96(5): 1003-1012.
|